Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Europe OKs Eli Lilly And Co Diagnostic For Likely Alzheimer's Cause-Reuters


Tuesday, 15 Jan 2013 04:40pm EST 

Reuters reported that European health regulators have approved Eli Lilly And Co's imaging agent used to detect brain plaques that are considered a likely cause of Alzheimer's disease. It was approved in Europe for use in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of memory and reasoning problems. 

Company Quote

53.547
0.913 +1.73%
31 Oct 2014